Northwind Pharmaceuticals LLC recalls Glimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and b)90-count bottles (NDC 51655-383-
Recalled May 3, 2023 · FDA recall D-0551-2023 · Northwind Pharmaceuticals
Hazard
CGMP Deviations · FDA Class II
Units
a) 230 bottles; b) 22 bottles
Sold at
Nationwide with the United States
Description
CGMP Deviations
Product
Glimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and b)90-count bottles (NDC 51655-383-26), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.
Manufacturer(s)
Northwind Pharmaceuticals LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →